Skip to main content
Livermore
Livermore
ZHEN

SG Americas Securities, LLC

SEC CIK
0001313360
Latest filing
Aug 7, 2026

MDGL holding history

Madrigal Pharmaceuticals, Inc. in every 13F filed by SG Americas Securities, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

MDGL overviewAll 13F holders of MDGLFull Q2 2026 holdings

Shares (Q2 2026)
8,170
Value
$4.39M
% of portfolio
<0.1%
Quarters held
17
Since Q1 2021
Holdings of MDGL by SG Americas Securities, LLC, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 20268,170$4.39M<0.1%+5,459+201.4%AddedHolders
Q1 20262,711$1.42M<0.1%−3,675−57.5%ReducedHolders
Q4 20256,386$3.72M<0.1%+1,195+23.0%AddedHolders
Q3 20255,191$2.38M<0.1%+5,191NewHolders
Q2 20250$00.0%−737−100.0%Sold outHolders
Q1 2025737$244.0K<0.1%+737NewHolders
Q4 20240$00.0%−1,951−100.0%Sold outHolders
Q3 20241,951$414.0K<0.1%+1,951NewHolders
Q2 20240$00.0%−1,347−100.0%Sold outHolders
Q1 20241,347$360.0K<0.1%+1,347NewHolders
Q4 20230$00.0%−4,436−100.0%Sold outHolders
Q3 20234,436$648.0K<0.1%+4,436NewHolders
Q2 20230$00.0%−7,132−100.0%Sold outHolders
Q1 20237,132$1.73M<0.1%+6,021+541.9%AddedHolders
Q4 20221,111$322.0K<0.1%−7,387−86.9%ReducedHolders
Q3 20228,498$552.0K<0.1%−10,947−56.3%ReducedHolders
Q2 202219,445$1.39M<0.1%−12,424−39.0%ReducedHolders
Q1 202231,869$3.13M<0.1%+17,968+129.3%AddedHolders
Q4 202113,901$1.18M<0.1%−19,784−58.7%ReducedHolders
Q3 202133,685$2.69M<0.1%+9,094+37.0%AddedHolders
Q2 202124,591$2.40M<0.1%−1,931−7.3%ReducedHolders
Q1 202126,522$3.10M<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.